Loading...
Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia
Chimeric antigen receptor (CAR) T-cell therapies that specifically target the CD19 antigen have emerged as a highly effective treatment option in patients with refractory B-cell hematological malignancies. Safety and efficacy outcomes from the pivotal prospective clinical trials of axicabtagene cilo...
Saved in:
| Published in: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047987/ https://ncbi.nlm.nih.gov/pubmed/33846220 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002056 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|